UNSPSC 85819117: Transfusion of nonautologous antihemophilic factors into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous antihemophilic factors into peripheral artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30253V1

UNSPSC 85819117 Transfusion of nonautologous antihemophilic factors into peripheral artery, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its nominal clinical scope. The six recent state and local contract opportunities tagged under this code cover occupational medical surveillance services, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve transfusion of antihemophilic factors or related blood-product administration. This mismatch suggests the code has been applied inconsistently or that state and local procurement systems are using it as a catch-all classification for medical benefit or clinical services that do not fit the code's intended meaning.

Across the six opportunities, issuing bodies include a city retirement office (Phoenix), two municipal health authorities (Long Beach, Santa Clara County), a state transportation department (Washington), a county juvenile justice system (Harris County), and a county benefits consortium (Collier County). The opportunities span Arizona, California, Washington, Texas, and Florida, with most posting dates in August and September 2026 and response deadlines ranging from September 25 to October 16, 2026. None of these opportunities are expressly seeking products or services related to blood-product transfusion or hemophilia treatment; the code's application appears to be administrative artifact rather than a genuine signal of procurement demand in this commodity family.